Source: Olivier Chassignole/AFP via Getty Images
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • The Federal Government had decided against ordering any single-dose COVID-19 vaccines from drugmaker Johnson & Johnson, despite a shortage of jabs
  • The Morrison Government is under increasing pressure to secure more vaccines for Australia after the AstraZeneca jab was ruled out for under-50s
  • But, Health Minister Greg Hunt’s office said the Johnson & Johnson vaccine was too similar to AstraZeneca’s jab to be considered an alternative
  • His decision comes as Australia recorded its first death from COVID-19 after an 80-year-old man from the Philippines died in hospital in Brisbane
  • The deceased man tested positive for the virus late last month while in hotel quarantine and passed away on April 12

The Federal Government had announced it won’t be ordering any single-dose COVID-19 vaccines from drugmaker Johnson & Johnson.

The decision comes despite the Morrison Government falling under increasing pressure to secure more vaccines after the AstraZeneca jab was ruled out for under-50s due to a rare blood clotting risk.

But, Health Minister Greg Hunt’s office has told the ABC that the Johnson & Johnson vaccine, which is being used throughout the U.S., was too similar to AstraZeneca’s jab to be considered a viable replacement.

The government’s decision comes as Australia recorded its first death from COVID-19 in recent months, with an 80-year-old man from the Philippines dying in hospital in Brisbane.

Local health authorities said the deceased man tested positive for the virus late last month while in hotel quarantine in the state before he passed away while in hospital care on Monday, April 12.

Meanwhile, Labor has intensified its attacks on the Federal Government’s handling of the vaccine rollout — accusing it of “botching” the plan.

Former Opposition Leader Bill Shorten said the government must act to restore confidence in the jab rollout.

“It’s a very bad week for timelines for Australians. The reality is that Australians are being held hostage to a botched vaccine rollout,” he told Nine.

“I mean, people were hoping that the vaccines were a path or a ticket back to normal. But now we find out that travel might not be a thing until 2024,” he said.

“It’s really, I think, undermined the confidence of a lot of Australians, especially younger ones, in the vaccine program full stop. It’s very bad news,” he added.

More From The Market Online
AI concept

The great AI scare sell-off is still permeating Wall Street; a speculative blog from the not-so-distant future stands as the latest culprit

The ongoing tech sell-off in the United States, ironically driven by the larger AI thematic itself, continues to define
US and Aus flag

The XJO benefitted from geopolitical calm last week. New tariff fears perhaps feel more familiar

Last week, I wrote that the ASX200 was having a good week, where Australian investors were reacting to Australian earnings reports and how

Okay, so just where is gold heading? Experts say its nowhere near finishline yet

Leading industry, government and investment groups are still confident that the gold’s bull run is nowhere…
Koala share trading AI

The ASX 200 is up over 4% YTD. What EOY targets are floating around?

It’s been a pretty good year for the ASX200 so far, helped greatly by the ‘commodity supercycle’ narrative – which isn’t really a